RE:Wake up - no deal coming.Wabbit, there is a deal coming. I understand the bitterness but don't forget that everyone loved this company and management coming up to ADCOM including Ispen. All articles quoted the risk based on the trial size and structure yet the FDA allowed and gave it priority, on top of that experts in the financial industry supported it.
I'm confident that they understand that they have taken it as far as they can and will pass it on to a company that has the finances and expertise to move it as far as it's destined to go.